心得安治疗婴儿血管瘤应用进展(6)
[15]Koka K，Mukherjee B，Agarkar S.Effect of oral propranolol on periocular capillary hemangiomas of infancy[J].Pediatr Neonatol，2018，59(4)：390-396.
[16]Ginguerra MA，Saito O，Fernandes JBVD.Clinical and radiological evaluation of periocular infantile hemangioma treated with oral propranolol：a case series[J].Am J Ophthalmol，2018，185：48-55.
[17]Janmohamed J，Trifunovic B，Vukomanovic G，et al.Oral propranolol for infantile hemangiomas：a prospective study on the role of 48-hour Holter monitoring in additional safety assessment[J].J Dermatolog Treat，2017，28(6)：554-558.
, http://www.100md.com
[18]Moodley ST，Hudson DA，Adams S，et al.Shouldn't propranolol be used to treat all haemangiomas？ [J].Aesthetic Plast Surg，2015，39(6)：963-967.
[19]Hengst M，Oelert M，Hoeger PH.Blood pressure monitoring during the induction and maintenance period of propranolol therapy for complicated infantile hemangiomas：a prospective study of 109 infants[J]. Pediatr Dermatol，2015，32(6)：802-807.
[20]Rouhana HF，Fruge JH，Massengale WT.Beta blocker treatment for infantile hemangiomas[J].Dermatol Online J，2015，21(7)：pii：13030.
, 百拇医药
[21]MacIsaac ZM，Nayar HS，Gehris R，et al.Treatment for infantile hemangiomas： selection criteria， safety， and outcomes using oral propranolol during the early phase of propranolol use for hemangiomas[J].J Craniofac Surg，2016，27(1)：159-162.
[22]Karimi S，Nikkhah H，Ahmadieh H.Intravitreal injection of propranolol for the treatment of retinal capillary hemangioma in a case of von hippel-lindau[J].Retin Cases Brief Rep，2018，19.doi：10.1097.
, 百拇医药
[23]Chang L，Chen H，Yang X.Intralesional Bleomycin Injection for Propranolol-Resistant Hemangiomas[J].J Craniofac Surg，2018，29(2)：e128-e130.
[24]Mashiah J，Kutz A，Rabia SH，5et al，Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas[J].Int J Dermatol，2017，56(2)：148-153.
[25]Marey HM，Elmazar HF，Mandour SS，et al.Combined oral and topical beta blockers for the treatment of early proliferative superficial periocular infantile capillary hemangioma[J].J Pediatr Ophthalmol Strabismus，2018，55(1)：37-42.
, 百拇医药
[26]Zheng L，Li Y.Effect of topical timolol on response rate and adverse events in infantile hemangioma：a meta-analysis[J].Arch Dermatol Res，2018，310(4)：261-269.
[27]Guo X，Zhu X，Gao J，et al.PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma[J].Nanomedicine (Lond)，2017，12(21)：2611-2624.
[28]González-Llorente N，Del Olmo-Benito I，Mu?oz-Ollero N，et al.Study of cognitive function in children treated with propranolol for infantile hemangioma[J].Pediatr Dermatol，2017，34(5)：554-558., http://www.100md.com(李荟元)
[16]Ginguerra MA，Saito O，Fernandes JBVD.Clinical and radiological evaluation of periocular infantile hemangioma treated with oral propranolol：a case series[J].Am J Ophthalmol，2018，185：48-55.
[17]Janmohamed J，Trifunovic B，Vukomanovic G，et al.Oral propranolol for infantile hemangiomas：a prospective study on the role of 48-hour Holter monitoring in additional safety assessment[J].J Dermatolog Treat，2017，28(6)：554-558.
, http://www.100md.com
[18]Moodley ST，Hudson DA，Adams S，et al.Shouldn't propranolol be used to treat all haemangiomas？ [J].Aesthetic Plast Surg，2015，39(6)：963-967.
[19]Hengst M，Oelert M，Hoeger PH.Blood pressure monitoring during the induction and maintenance period of propranolol therapy for complicated infantile hemangiomas：a prospective study of 109 infants[J]. Pediatr Dermatol，2015，32(6)：802-807.
[20]Rouhana HF，Fruge JH，Massengale WT.Beta blocker treatment for infantile hemangiomas[J].Dermatol Online J，2015，21(7)：pii：13030.
, 百拇医药
[21]MacIsaac ZM，Nayar HS，Gehris R，et al.Treatment for infantile hemangiomas： selection criteria， safety， and outcomes using oral propranolol during the early phase of propranolol use for hemangiomas[J].J Craniofac Surg，2016，27(1)：159-162.
[22]Karimi S，Nikkhah H，Ahmadieh H.Intravitreal injection of propranolol for the treatment of retinal capillary hemangioma in a case of von hippel-lindau[J].Retin Cases Brief Rep，2018，19.doi：10.1097.
, 百拇医药
[23]Chang L，Chen H，Yang X.Intralesional Bleomycin Injection for Propranolol-Resistant Hemangiomas[J].J Craniofac Surg，2018，29(2)：e128-e130.
[24]Mashiah J，Kutz A，Rabia SH，5et al，Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas[J].Int J Dermatol，2017，56(2)：148-153.
[25]Marey HM，Elmazar HF，Mandour SS，et al.Combined oral and topical beta blockers for the treatment of early proliferative superficial periocular infantile capillary hemangioma[J].J Pediatr Ophthalmol Strabismus，2018，55(1)：37-42.
, 百拇医药
[26]Zheng L，Li Y.Effect of topical timolol on response rate and adverse events in infantile hemangioma：a meta-analysis[J].Arch Dermatol Res，2018，310(4)：261-269.
[27]Guo X，Zhu X，Gao J，et al.PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma[J].Nanomedicine (Lond)，2017，12(21)：2611-2624.
[28]González-Llorente N，Del Olmo-Benito I，Mu?oz-Ollero N，et al.Study of cognitive function in children treated with propranolol for infantile hemangioma[J].Pediatr Dermatol，2017，34(5)：554-558., http://www.100md.com(李荟元)